• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tevogen Bio Holdings Inc. - Common Stock (NQ:TVGN)

    6.140 -0.150 (-2.38%)
    Streaming Delayed Price Updated: 9:52 AM EDT, Jun 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,631
    Open 6.280
    Bid (Size) 6.200 (100)
    Ask (Size) 6.530 (100)
    Prev. Close 6.290
    Today's Range 6.130 - 6.280
    52wk Range 4.135 - 71.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Tevogen Announces Formation of a Healthcare Services Initiative
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
    From Tevogen Bio Inc
    Via GlobeNewswire

    Performance

    YTD
    -66.2%
    -66.2%
    1 Month
    -23.7%
    -23.7%
    3 Month
    +43.1%
    +43.1%
    6 Month
    -64.8%
    -64.8%
    1 Year
    -90.2%
    -90.2%

    More News

    Read More
    News headline image
    Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Letter to Shareholders from CEO Dr. Ryan Saadi
    From Tevogen Bio Inc
    Via GlobeNewswire
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
    From Tevogen Bio Inc
    Via GlobeNewswire
    What's going on in today's pre-market session ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Tevogen Names Leadership Team to Execute Diversified Growth Strategy
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen CEO Says ‘Actively Evaluating’ Potential Acquisitions ↗
    Via Stocktwits
    News headline image
    Letter to Shareholders from CEO Dr. Ryan Saadi
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Shares Take Further Beating On Gauging Deal With Apozel Pharmaceuticals ↗
    Via Stocktwits
    News headline image
    Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
    From Tevogen Bio Inc
    Via GlobeNewswire
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Tevogen Announces Reverse Stock Split
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
    From Tevogen Bio Inc
    Via GlobeNewswire

    Frequently Asked Questions

    Is Tevogen Bio Holdings Inc. - Common Stock publicly traded?
    Yes, Tevogen Bio Holdings Inc. - Common Stock is publicly traded.
    What exchange does Tevogen Bio Holdings Inc. - Common Stock trade on?
    Tevogen Bio Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tevogen Bio Holdings Inc. - Common Stock?
    The ticker symbol for Tevogen Bio Holdings Inc. - Common Stock is TVGN on the Nasdaq Stock Market
    What is the current price of Tevogen Bio Holdings Inc. - Common Stock?
    The current price of Tevogen Bio Holdings Inc. - Common Stock is 6.140
    When was Tevogen Bio Holdings Inc. - Common Stock last traded?
    The last trade of Tevogen Bio Holdings Inc. - Common Stock was at 06/30/26 09:52 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.